Zobrazeno 1 - 3
of 3
pro vyhledávání: '"IDB0076"'
Autor:
Jong-Hee Ko, Hyuk-Sang Kwon, Bomin Kim, Gihong Min, Chorong Shin, Seok-Woo Yang, Seong Wook Lee, Youngmin Lee, Dahae Hong, Yong-Sung Kim
Publikováno v:
Biomolecules, Vol 10, Iss 6, p 919 (2020)
Although bevacizumab (Avastin®) has been approved as an antiangiogenic agent against some cancers, the efficacy is transient and unsatisfactory in other cancers most likely owing to the presence of alternative proangiogenic factors. Therefore, simul
Externí odkaz:
https://doaj.org/article/d734c11c4d374bd095a4f1a1a34a1d76
Autor:
Hyuk-Sang Kwon, Dahae Hong, Seok-Woo Yang, Chorong Shin, Gihong Min, Youngmin Lee, Yong Sung Kim, Bomin Kim, Jong-Hee Ko, Seong Wook Lee
Publikováno v:
Biomolecules
Volume 10
Issue 6
Biomolecules, Vol 10, Iss 919, p 919 (2020)
Volume 10
Issue 6
Biomolecules, Vol 10, Iss 919, p 919 (2020)
Although bevacizumab (Avastin®
) has been approved as an antiangiogenic agent against some cancers, the efficacy is transient and unsatisfactory in other cancers most likely owing to the presence of alternative proangiogenic factors. Therefor
) has been approved as an antiangiogenic agent against some cancers, the efficacy is transient and unsatisfactory in other cancers most likely owing to the presence of alternative proangiogenic factors. Therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b95416e85f54443721276c8d44b3767
https://doi.org/10.3390/biom10060919
https://doi.org/10.3390/biom10060919
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.